Innovation in Neurosurgery
If a neurosurgeon develops a new technique, when can it be considered innovation, and when should it be considered investigation? How novel must the technique be, before specific consent is required from the patient? When should regulatory authorities review the technique?
We discussed these questions and more with two neurosurgeons experienced in innovation, bioethics, the law, and international regulation.
Joseph Madsen, MD, Director, Epilepsy Surgery, Children's Hospital Boston
Marieke Broekman MD, PhD, JD, Neurosurgery, University Medical Center Utrecht
Ways to Join
This event was free and open to the public.
Neuroethics Seminar Series
This event is part of a series hosted by the Center for Biothics at Harvard Medical School. For more information, visit the website.
The International Neuroethics Society
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard Law School
Center for Law, Brain and Behavior, MGH
Institute for the Neurosciences, BWH
Center for Brain Science, Harvard University
Department of Neurobiology, Harvard Medical School
With funding from
Mind Brain Behavior Interfaculty Initiative, Harvard University
The Harvard Brain Initiative Collaborative Seed Grant Program